Equities Research Analysts’ upgrades for Friday, July 21st: Abbott Laboratories (NYSE:ABT) was upgraded by analysts at Wolfe Research from an underperform rating to a peer perform rating. Aker BP ASA (OTCMKTS:AKRBF) was upgraded by analysts at Berenberg Bank from a hold rating to a buy rating. Aker BP ASA (OTCMKTS:AKRBF) was upgraded by analysts at […]
Mitsubishi UFJ Asset Management UK Ltd. purchased a new position in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 21,000 shares of the medical device company’s stock, valued at approximately […]
Banque Pictet & Cie SA lessened its stake in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 35.9% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 60,305 shares of the medical device company’s stock after selling 33,789 shares during the quarter. […]
StockNews.com downgraded shares of DexCom (NASDAQ:DXCM – Free Report) from a buy rating to a hold rating in a report issued on Thursday morning. A number of other analysts have also commented on DXCM. Barclays lifted their target price on shares of DexCom from $110.00 to $115.00 in a report on Monday, May 1st. Citigroup […]